Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years

In 2018, the Food and Drug Administration expanded the age of eligibility for the human papillomavirus (HPV) vaccine to 27 to 45 years. However, it is unclear if there are racial/ethnic disparities in HPV vaccine uptake for this age-group following this expanded recommendation. We aimed to identify...

Full description

Bibliographic Details
Published in:Human Vaccines & Immunotherapeutics
Main Authors: Natalie L. Rincon, Kelsey Rae McDowell, Darien Weatherspoon, Tiarney D. Ritchwood, Daniel J. Rocke, Eric Adjei Boakye, Nosayaba Osazuwa-Peters
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2313249